Literature DB >> 23797373

[Interventional Mitral valve repair with the MitraClip® procedure. Patient selection criteria].

D Braun1, M Orban, J Tittus, M Näbauer, C Hagl, S Massberg, J Hausleiter.   

Abstract

In current practice the MitraClip® procedure is increasingly being used for patients unsuitable or at high risk for cardiac surgery. This article initially describes the patient groups that are suitable for percutaneous edge-to-edge repair. For this purpose the echocardiographic criteria for severe mitral regurgitation are first characterized and treatment algorithms for patients with primary as well as secondary mitral regurgitation according to current guidelines are illustrated. Basic anatomical requirements for the successful implantation of a MitraClip® are described and a distinction is made between various valve morphologies ranging from optimal to unsuitable anatomical conditions. Finally, three patient groups eligible for percutaneous edge-to-edge repair considering clinical and anatomical criteria are defined: (1) optimal for MitraClip®, (2) MitraClip® could be considered and (3) MitraClip® only in exceptional cases.

Entities:  

Mesh:

Year:  2013        PMID: 23797373     DOI: 10.1007/s00059-013-3857-4

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  13 in total

1.  Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by MitraClip improves symptoms and promotes reverse remodeling.

Authors:  Angelo Auricchio; Wolfgang Schillinger; Sven Meyer; Francesco Maisano; Rainer Hoffmann; Gian Paolo Ussia; Giovanni B Pedrazzini; Jan van der Heyden; Simona Fratini; Catherine Klersy; Jan Komtebedde; Olaf Franzen
Journal:  J Am Coll Cardiol       Date:  2011-11-15       Impact factor: 24.094

2.  Echocardiographic and clinical outcomes of MitraClip therapy in patients not amenable to surgery.

Authors:  Volker Rudolph; Malgorzata Knap; Olaf Franzen; Michael Schlüter; Tjark de Vries; Lenard Conradi; Johannes Schirmer; Hendrik Treede; Karl Wegscheider; Angelika Costard-Jäckle; Thomas Meinertz; Hermann Reichenspurner; Stephan Baldus
Journal:  J Am Coll Cardiol       Date:  2011-11-15       Impact factor: 24.094

3.  Left ventricular thrombus formation after successful percutaneous edge-to-edge mitral valve repair.

Authors:  Martin Orban; Hasema Lesevic; Steffen Massberg; Jörg Hausleiter
Journal:  Eur Heart J       Date:  2012-08-16       Impact factor: 29.983

4.  Guidelines on the management of valvular heart disease (version 2012).

Authors:  Alec Vahanian; Ottavio Alfieri; Felicita Andreotti; Manuel J Antunes; Gonzalo Barón-Esquivias; Helmut Baumgartner; Michael Andrew Borger; Thierry P Carrel; Michele De Bonis; Arturo Evangelista; Volkmar Falk; Bernard Iung; Patrizio Lancellotti; Luc Pierard; Susanna Price; Hans-Joachim Schäfers; Gerhard Schuler; Janina Stepinska; Karl Swedberg; Johanna Takkenberg; Ulrich Otto Von Oppell; Stephan Windecker; Jose Luis Zamorano; Marian Zembala
Journal:  Eur Heart J       Date:  2012-08-24       Impact factor: 29.983

5.  Age-related prevalence of valvular regurgitation in normal subjects: a comprehensive color flow examination of 118 volunteers.

Authors:  A L Klein; D J Burstow; A J Tajik; P K Zachariah; C P Taliercio; C L Taylor; K R Bailey; J B Seward
Journal:  J Am Soc Echocardiogr       Date:  1990 Jan-Feb       Impact factor: 5.251

6.  Percutaneous repair or surgery for mitral regurgitation.

Authors:  Ted Feldman; Elyse Foster; Donald D Glower; Donald G Glower; Saibal Kar; Michael J Rinaldi; Peter S Fail; Richard W Smalling; Robert Siegel; Geoffrey A Rose; Eric Engeron; Catalin Loghin; Alfredo Trento; Eric R Skipper; Tommy Fudge; George V Letsou; Joseph M Massaro; Laura Mauri
Journal:  N Engl J Med       Date:  2011-04-04       Impact factor: 91.245

7.  Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study.

Authors:  Patrick L Whitlow; Ted Feldman; Wes R Pedersen; D Scott Lim; Robert Kipperman; Richard Smalling; Tanvir Bajwa; Howard C Herrmann; John Lasala; James T Maddux; Murat Tuzcu; Samir Kapadia; Alfredo Trento; Robert J Siegel; Elyse Foster; Donald Glower; Laura Mauri; Saibal Kar
Journal:  J Am Coll Cardiol       Date:  2012-01-10       Impact factor: 24.094

8.  MitraClip® therapy in patients with end-stage systolic heart failure.

Authors:  Olaf Franzen; Jan van der Heyden; Stephan Baldus; Michael Schlüter; Wolfgang Schillinger; Christian Butter; Rainer Hoffmann; Roberto Corti; Giovanni Pedrazzini; Martin J Swaans; Michael Neuss; Volker Rudolph; Daniel Sürder; Jürg Grünenfelder; Christine Eulenburg; Hermann Reichenspurner; Thomas Meinertz; Angelo Auricchio
Journal:  Eur J Heart Fail       Date:  2011-04-06       Impact factor: 15.534

9.  A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease.

Authors:  Bernard Iung; Gabriel Baron; Eric G Butchart; François Delahaye; Christa Gohlke-Bärwolf; Olaf W Levang; Pilar Tornos; Jean-Louis Vanoverschelde; Frank Vermeer; Eric Boersma; Philippe Ravaud; Alec Vahanian
Journal:  Eur Heart J       Date:  2003-07       Impact factor: 29.983

10.  Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort.

Authors:  Ted Feldman; Saibal Kar; Michael Rinaldi; Peter Fail; James Hermiller; Richard Smalling; Patrick L Whitlow; William Gray; Reginald Low; Howard C Herrmann; Scott Lim; Elyse Foster; Donald Glower
Journal:  J Am Coll Cardiol       Date:  2009-08-18       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.